These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33205916)

  • 1. Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction.
    Matsushita K; Marchandot B; Carmona A; Curtiaud A; El Idrissi A; Trimaille A; Kibler M; Cardi T; Heger J; Hess S; Reydel A; Jesel L; Ohlmann P; Morel O
    ESC Heart Fail; 2021 Feb; 8(1):380-389. PubMed ID: 33205916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.
    Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers in Acute Coronary Syndrome and Preserved Ventricular Ejection Fraction.
    Cespón-Fernández M; Raposeiras-Roubín S; Abu-Assi E; Pousa IM; Queija BC; Paz RJC; Erquicia PD; Rodríguez LMD; Rodríguez EL; Busto MC; Barbeira SF; Romo AÍ
    Angiology; 2020 Nov; 71(10):886-893. PubMed ID: 32757765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of left ventricular function on clinical outcomes among patients with coronary artery disease.
    Siontis GC; Branca M; Serruys P; Silber S; Räber L; Pilgrim T; Valgimigli M; Heg D; Windecker S; Hunziker L
    Eur J Prev Cardiol; 2019 Aug; 26(12):1273-1284. PubMed ID: 30966820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical conditions and echocardiographic parameters associated with mortality in COVID-19.
    Silverio A; Di Maio M; Scudiero F; Russo V; Esposito L; Attena E; Pezzullo S; Parodi G; D'Andrea A; Damato A; Silvestro A; Iannece P; Bellino M; Di Vece D; Borrelli A; Citro R; Vecchione C; Galasso G
    Eur J Clin Invest; 2021 Dec; 51(12):e13638. PubMed ID: 34287861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.
    Agra Bermejo R; Cordero A; García-Acuña JM; Gómez Otero I; Varela Román A; Martínez Á; Álvarez Rodríguez L; Abou-Jokh C; Rodríguez-Mañero M; Cid Álvarez B; López-Palop R; Carrillo P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):820-828. PubMed ID: 29249471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Left Ventricular Systolic Function Improvement Following Coronary Artery Revascularization in Heart Failure Patients With Reduced Ejection Fraction (HFrEF).
    Adachi Y; Sakakura K; Wada H; Funayama H; Umemoto T; Fujita H; Momomura S
    Int Heart J; 2016 Sep; 57(5):565-72. PubMed ID: 27628418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile and 30-Day Mortality of Invasively Managed Patients with Suspected Acute Coronary Syndrome During the COVID-19 Outbreak.
    Salinas P; Travieso A; Vergara-Uzcategui C; Tirado-Conte G; Macaya F; Mejía-Rentería H; Nombela-Franco L; Núñez-Gil IJ; Gonzalo N; Jiménez-Quevedo P; Pérez-Vizcayno MJ; Escaned J; Fernández-Ortiz A
    Int Heart J; 2021 Mar; 62(2):274-281. PubMed ID: 33731529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction.
    Furtado RHM; Juliasz MG; Chiu FYJ; Bastos LBC; Dalcoquio TF; Lima FG; Rosa R; Caporrino CA; Bertolin A; Genestreti PRR; Ribeiro AS; Andrade MC; Giraldez RRCV; Baracioli LM; Zelniker TA; Nicolau JC
    ESC Heart Fail; 2023 Feb; 10(1):442-452. PubMed ID: 36274250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
    Raposeiras-Roubín S; Abu-Assi E; Redondo-Diéguez A; González-Ferreiro R; López-López A; Bouzas-Cruz N; Castiñeira-Busto M; Peña Gil C; García-Acuña JM; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):585-91. PubMed ID: 25511558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
    Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
    BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial.
    Mukherjee JT; Beshansky JR; Ruthazer R; Alkofide H; Ray M; Kent D; Manning WJ; Huggins GS; Selker HP
    Cardiovasc Ultrasound; 2016 Aug; 14(1):29. PubMed ID: 27488569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.
    Biondi-Zoccai G; Sheiban I; Moretti C; Palmerini T; Marzocchi A; Capodanno D; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Pede Fd; Ramondo A; Medda M; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; de Servi S
    Clin Res Cardiol; 2011 May; 100(5):403-11. PubMed ID: 21128078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection.
    Morin DP; Manzo MA; Pantlin PG; Verma R; Bober RM; Krim SR; Lavie CJ; Qamruddin S; Shah S; Tafur Soto JD; Ventura H; Price-Haywood EG
    Curr Probl Cardiol; 2021 Oct; 46(10):100845. PubMed ID: 33994027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of baseline heart rate as a predictor of cardiac functional recovery in newly diagnosed heart failure with reduced ejection fraction.
    Valika A; Paprockas K; Villines D; Costanzo MR
    Clin Cardiol; 2018 Jun; 41(6):752-757. PubMed ID: 29512170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.